Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.
Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, Suzuki T, Koda Y, Chu PS, Taniki N, Yamaguchi A, Kanamori M, Kamada N, Hattori M, Ashida H, Sakamoto M, Atarashi K, Narushima S, Yoshimura A, Honda K, Sato T, Kanai T. Nakamoto N, et al. Among authors: yamaguchi a. Nat Microbiol. 2019 Mar;4(3):492-503. doi: 10.1038/s41564-018-0333-1. Epub 2019 Jan 14. Nat Microbiol. 2019. PMID: 30643240
Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.
Chu PS, Ebinuma H, Nakamoto N, Sugiyama K, Usui S, Wakayama Y, Taniki N, Yamaguchi A, Shiba S, Yamagishi Y, Wakita T, Hibi T, Saito H, Kanai T. Chu PS, et al. Among authors: yamaguchi a. PLoS One. 2015 May 12;10(5):e0125664. doi: 10.1371/journal.pone.0125664. eCollection 2015. PLoS One. 2015. PMID: 25965701 Free PMC article.
Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation.
Shinoda M, Ebinuma H, Itano O, Yamagishi Y, Obara H, Kitago M, Nakamoto N, Hibi T, Yagi H, Abe Y, Matsubara K, Chu PS, Wakayama Y, Taniki N, Yamaguchi A, Amemiya R, Miyake R, Mizota T, Kanai T, Kitagawa Y. Shinoda M, et al. Among authors: yamaguchi a. Hepatol Res. 2016 Oct;46(11):1118-1128. doi: 10.1111/hepr.12666. Epub 2016 Apr 22. Hepatol Res. 2016. PMID: 26854748
On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.
Chu PS, Nakamoto N, Taniki N, Ojiro K, Amiya T, Makita Y, Murata H, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ugamura A, Ikura A, Takeda K, Ebinuma H, Saito H, Kanai T. Chu PS, et al. Among authors: yamaguchi a. PLoS One. 2017 Jun 15;12(6):e0179096. doi: 10.1371/journal.pone.0179096. eCollection 2017. PLoS One. 2017. PMID: 28617830 Free PMC article.
Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice.
Nakamoto N, Amiya T, Aoki R, Taniki N, Koda Y, Miyamoto K, Teratani T, Suzuki T, Chiba S, Chu PS, Hayashi A, Yamaguchi A, Shiba S, Miyake R, Katayama T, Suda W, Mikami Y, Kamada N, Ebinuma H, Saito H, Hattori M, Kanai T. Nakamoto N, et al. Among authors: yamaguchi a. Cell Rep. 2017 Oct 31;21(5):1215-1226. doi: 10.1016/j.celrep.2017.10.022. Cell Rep. 2017. PMID: 29091761 Free article.
Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.
Taniki N, Nakamoto N, Chu PS, Mikami Y, Amiya T, Teratani T, Suzuki T, Tsukimi T, Fukuda S, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ebinuma H, Kanai T. Taniki N, et al. Among authors: yamaguchi a. JCI Insight. 2018 Jun 21;3(12):e91980. doi: 10.1172/jci.insight.91980. eCollection 2018 Jun 21. JCI Insight. 2018. PMID: 29925685 Free PMC article.
Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure.
Ugamura A, Chu PS, Nakamoto N, Taniki N, Ojiro K, Hibi T, Shinoda M, Obara H, Masugi Y, Yamaguchi A, Shiba S, Morikawa R, Usui S, Ebinuma H, Kitagawa Y, Saito H, Kanai T. Ugamura A, et al. Among authors: yamaguchi a. Hepatol Commun. 2018 Sep 21;2(11):1331-1343. doi: 10.1002/hep4.1233. eCollection 2018 Nov. Hepatol Commun. 2018. PMID: 30411080 Free PMC article.
Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35.
Koda Y, Nakamoto N, Chu PS, Ugamura A, Mikami Y, Teratani T, Tsujikawa H, Shiba S, Taniki N, Sujino T, Miyamoto K, Suzuki T, Yamaguchi A, Morikawa R, Sato K, Sakamoto M, Yoshimoto T, Kanai T. Koda Y, et al. Among authors: yamaguchi a. J Clin Invest. 2019 Jul 2;129(8):3201-3213. doi: 10.1172/JCI125863. eCollection 2019 Jul 2. J Clin Invest. 2019. PMID: 31264967 Free PMC article.
2,824 results